免疫化学放射線療法
Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer: The Phase III PACIFIC-2 StudyBradley JD, Sugawara S, Lee KH, et al. J Clin Oncol. 2025 Oct 13:JCO2500036. doi: 10.1200/JCO-2…
Durvalumab With or Without Tremelimumab in Combination With Chemoradiotherapy in Patients With Limited-Stage SCLC: Results from the Phase 1 CLOVER Study.Cho BC, Ahn MJ, Nishio M, et al. JTO Clin Res Rep. 2025 Aug 5;6(10):100884. doi: 10.10…
Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial.Mayadev J, Zamarin D, Deng W, et al. Nat Commun. 2025 Jan 9;16(1):553. doi: 10.1038/s41467-024-55200-2. PMID: 39788…
Randomized Phase II Study of Concurrent Versus Sequential Pembrolizumab in Combination With Chemoradiation in Locally Advanced Head and Neck Cancer. Zandberg DP, Vujanovic L, Clump DA, et al. J Clin Oncol. 2025 Aug 10;43(23):2572-2582. doi…
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-bli…
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial.Lor…
Real-world study of first-line immunotherapy combined with chemoradiotherapy in esophageal squamous cell carcinoma.Zhao X, Weng C, Yang W, et al. Sci Rep. 2025 Aug 4;15(1):28343. DOI: 10.1038/s41598-025-12250-w PMID: 40760130. 【概要】・免…
Nivolumab adjuvant to chemo-radiation in localized muscle-invasive urothelial cancer: primary analysis of a multicenter, single-arm, phase II, investigator-initiated trial (NEXT).Galarza Fortuna GM, Grass D, Maughan BL, et al. J Immunother…
Neoadjuvant chemoradiotherapy with or without PD-1/PD-L1 inhibitors in locally advanced rectal cancer: a systematic review and meta-analysis.Ansab M, Razi S, Nisa F, et al. BMC Cancer. 2025 Jul 1;25(1):1084. doi: 10.1186/s12885-025-14482-5…
